| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |